Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason H Kurzer

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Leukemia & Lymphoma|November 4, 2016
A replicable CD271+ mesenchymal stromal cell density score: bringing the dysfunctional myelodysplastic syndrome niche to the diagnostic laboratoryEric Gars, Sherif M Yousry, Daniel Babu, et al.
Cancer Cytopathology|September 9, 2018
Flow immunophenotyping of benign lymph nodes sampled by FNA: Representative with diagnostic pitfallsGregory D Scott, Hubert D Lau, Jason H Kurzer, et al.
Molecular and Cellular Biology|May 4, 2004
Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-B betaJason H Kurzer, Lawrence S Argetsinger, Yong-Jie Zhou, et al.
Analytical Chemistry|April 15, 2005
Capillary electrophoresis and fluorescence anisotropy for quantitative analysis of peptide-protein interactions using JAK2 and SH2-Bbeta as a model systemPeilin Yang, Rebecca J Whelan, Emily E Jameson, et al.
Cell Reports|April 26, 2018
SETDB2 Links E2A-PBX1 to Cell-Cycle Dysregulation in Acute Leukemia through CDKN2C RepressionChiou-Hong Lin, Stephen Hon-Kit Wong, Jason H Kurzer, et al.
Blood Advances|January 24, 2022
TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AMLOlga K Weinberg, Alexa Siddon, Yazan F Madanat, et al.
Cancer Research|October 21, 2016
E2A-PBX1 Remodels Oncogenic Signaling Networks in B-cell Precursor Acute Lymphoid LeukemiaJesús Duque-Afonso, Chiou-Hong Lin, Kyuho Han, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 20, 2019
Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology groupOlga K Weinberg, Robert P Hasserjian, Ezra Baraban, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2021
Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology GroupOlga K Weinberg, Karen M Chisholm, Chi Young Ok, et al.
Leukemia Research|November 4, 2022
NPM1 mutations may be associated with adverse outcome in the setting of myeloid neoplasms with complex karyotypeMaximiliano Ramia de Cap, Leo P Wu, German A Pihan, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Leukemia & Lymphoma|November 4, 2016
A replicable CD271+ mesenchymal stromal cell density score: bringing the dysfunctional myelodysplastic syndrome niche to the diagnostic laboratoryEric Gars, Sherif M Yousry, Daniel Babu, et al.
Cancer Cytopathology|September 9, 2018
Flow immunophenotyping of benign lymph nodes sampled by FNA: Representative with diagnostic pitfallsGregory D Scott, Hubert D Lau, Jason H Kurzer, et al.
Molecular and Cellular Biology|May 4, 2004
Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-B betaJason H Kurzer, Lawrence S Argetsinger, Yong-Jie Zhou, et al.
Analytical Chemistry|April 15, 2005
Capillary electrophoresis and fluorescence anisotropy for quantitative analysis of peptide-protein interactions using JAK2 and SH2-Bbeta as a model systemPeilin Yang, Rebecca J Whelan, Emily E Jameson, et al.
Cell Reports|April 26, 2018
SETDB2 Links E2A-PBX1 to Cell-Cycle Dysregulation in Acute Leukemia through CDKN2C RepressionChiou-Hong Lin, Stephen Hon-Kit Wong, Jason H Kurzer, et al.
Blood Advances|January 24, 2022
TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AMLOlga K Weinberg, Alexa Siddon, Yazan F Madanat, et al.
Cancer Research|October 21, 2016
E2A-PBX1 Remodels Oncogenic Signaling Networks in B-cell Precursor Acute Lymphoid LeukemiaJesús Duque-Afonso, Chiou-Hong Lin, Kyuho Han, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 20, 2019
Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology groupOlga K Weinberg, Robert P Hasserjian, Ezra Baraban, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2021
Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology GroupOlga K Weinberg, Karen M Chisholm, Chi Young Ok, et al.
Leukemia Research|November 4, 2022
NPM1 mutations may be associated with adverse outcome in the setting of myeloid neoplasms with complex karyotypeMaximiliano Ramia de Cap, Leo P Wu, German A Pihan, et al.
Pageof 3